K M Prasanna Kumar
Overview
Explore the profile of K M Prasanna Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prasanna Kumar K, Chowdhury S, Bantwal G, Unnikrishnan A, Kalra S, Aggarwal S, et al.
Cureus
. 2024 Jun;
16(5):e60983.
PMID: 38910730
Achieving and maintaining optimal glycemic targets is the fundamental goal of the management of diabetes. However, failure of oral antidiabetic drugs (OADs) to sustain the targeted glycemic levels in individuals...
2.
Prasanna Kumar K, Unnikrishnan A, Jariwala P, Mehta A, Chaturvedi R, Panchal S, et al.
Indian J Endocrinol Metab
. 2024 Mar;
28(1):11-18.
PMID: 38533279
The prevalence and burden of diabetes are on the rise in India, making it 'the diabetes capital of the world'. Comorbidities such as obesity, cardiovascular (CV) complications, chronic kidney disease...
3.
Das A, Kalra S, Joshi S, Mithal A, Prasanna Kumar K, Unnikrishnan A, et al.
Endocrinol Diabetes Metab
. 2023 Jul;
6(5):e422.
PMID: 37392036
Introduction: LANDMARC (CTRI/2017/05/008452), a prospective, observational real-world study, evaluated the occurrence of diabetes complications, glycemic control and treatment patterns in people with type 2 diabetes mellitus (T2DM) from pan-India regions...
4.
Kalra S, Unnikrishnan A, Prasanna Kumar K, Sahay R, Chandalia H, Saboo B, et al.
Diabetes Ther
. 2023 Feb;
14(4):787.
PMID: 36806989
No abstract available.
5.
Kalra S, Unnikrishnan A, Prasanna Kumar K, Sahay R, Chandalia H, Saboo B, et al.
Diabetes Ther
. 2022 Nov;
14(1):29-45.
PMID: 36380217
With the emerging complexities in chronic diseases and people's lifestyles, healthcare professionals (HCPs) need to update their methods to manage and educate patients with chronic lifestyle disorders, particularly diabetes. The...
6.
Das A, Mithal A, Joshi S, Prasanna Kumar K, Kalra S, Unnikrishnan A, et al.
Endocrinol Diabetes Metab
. 2021 Jul;
4(3):e00231.
PMID: 34277959
Introduction: Longitudinal data on progression, complications, and management of type 2 diabetes mellitus (T2DM) across India are scarce. LANDMARC (CTRI/2017/05/008452), the first -India, longitudinal, prospective, observational study, aims to understand...
7.
Prasanna Kumar K, Seshadri K, Aravind S, Deb P, Modi K, Gopal R, et al.
Cureus
. 2021 Mar;
13(1):e13020.
PMID: 33665047
Background Type 2 diabetes mellitus (T2DM) is associated with a significant burden on both patients and the healthcare system. This study aimed to evaluate the demographics of patients with T2DM ...
8.
Bhatia A, Tawade S, Mastim M, Kitabi E, Gopalakrishnan M, Shah M, et al.
Acta Diabetol
. 2020 Nov;
58(1):129-130.
PMID: 33201346
No abstract available.
9.
Arya D, Chowdhury S, Chawla R, Das A, Ganie M, Prasanna Kumar K, et al.
J Assoc Physicians India
. 2019 Dec;
67(12):58-64.
PMID: 31801333
Pharmacotherapy with fixed dose combination (FDC) drugs is becoming popular as evidence-based clinical guidelines recommend using multiple therapeutic agents in complex regimens for many chronic diseases including type 2 diabetes...
10.
Prasanna Kumar K, Chawla M, Sanghvi A, Sastry N, Kotla C, Phatak S, et al.
Int J Gen Med
. 2019 May;
12:147-159.
PMID: 31040711
Purpose: The aim of this study was to understand patient adherence, satisfaction, and experience with the smaller sized metformin 500 mg prolonged release (PR) tablet that has been manufactured with...